HEALTHGUARDIAN US
Drugmaker Merck announces approval of new cholesterol-fighting drug
Merck received FDA approval for Lipfendra, a PCSK9 inhibitor that serves as an alternative to statins for managing high LDL cholesterol. Statins, while widely prescribed, can cause side effects like muscle aches and may not sufficiently lower cholesterol levels for some patients.
Related Signal
Adjacent reporting
- Merck won FDA approval for the first cholesterol pill to rival powerful injectables
- FDA approves new pill to slash cholesterol levels
- U.S. approves pill for cholesterol that drives levels down far below statins
- The use of cholesterol medication may stop cancer – and more health headlines
- Full list of prescription drugs - including cholesterol-busting medication taken by millions - that could see massive price cuts under Trump's new deal
- STAT+: AstraZeneca picks up FDA approval for hypertension drug